Medicare adds Alzheimer's screening to routine checkups for seniors
S. 1799 — A bill to amend title XVIII of the Social Security Act to provide for certain cognitive impairment detection in the Medicare annual wellness visit and initial preventative physical examination. · Filed by Shelley Capito (R-WV) · 2 cosponsors · Introduced May 19, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill requires Medicare to add cognitive impairment screening to two routine preventive visits: the annual wellness visit and the initial preventive physical exam. Doctors must use a screening tool approved by the National Institute on Aging and document results in the patient's medical record, starting January 1, 2026. The goal is early detection of Alzheimer's disease and dementia, which affects millions of older Americans.
Why we flagged it
The bill is a straightforward public health measure that mandates cognitive screening in Medicare preventive visits. It is not a tax provision, appropriation, or deregulation—it is a clinical requirement designed to improve early detection of a major disease affecting millions of seniors.
What the text implies
- Screening mandate may increase downstream diagnostic testing and specialist referrals, raising Medicare costs if not offset by early intervention savings.
- Standardized screening tools may create liability exposure for providers if cognitive impairment is detected but not acted upon or communicated clearly.
The full analysis lists 4 implications of this text.
Who stands to gain
pharmaceutical companies (Alzheimer's drug manufacturers); diagnostic testing labs; memory care and geriatric specialty clinics